NLSP — NLS Pharmaceutics AG

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $2.55 Analyst target: $6.00 Upside: 135.29%

See the full interactive analysis & chart →

Informational only — not investment advice.